← Leaderboards
Jessica Price
Columbia University Health Sciences
$224,160
Attributed
$224,160
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49K · FY2014–18$50K$37.5K$25K$12.5K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$224,160 · 1
By mechanism
F31$224,160 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Hasina Hamilton Outtz$4,286,571
- Kenneth P Olive$11,212,298
- Anil K Rustgi$51,275,906
- Peter D Canoll$11,470,200
- Jeffrey N Bruce$6,985,161
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisExcisionApoptosisAscitesEpithelial To Mesenchymal TransitionAngiogenesis InhibitorsBlood VesselsCancer CellCancer EtiologyCancer ModelBevacizumabCancer TherapyCell LineCellsCell SurvivalCessation Of LifeChemotherapyCisplatinCytotoxicityDensityDiagnosisDoseDrug ResistanceGene Amplification
Grant awards (5)
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer$43,443
F31 · FY2018 · CA · contact PI
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer$49,044
F31 · FY2017 · CA · contact PI
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer$44,343
F31 · FY2016 · CA · contact PI
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer$43,887
F31 · FY2015 · CA · contact PI
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer$43,443
F31 · FY2014 · CA · contact PI